Water-Jel Technologies Recalls Lidocaine Wound Gel
This is a Class III recall. This product is unlikely to cause adverse health reactions but violates FDA regulations.
Water-Jel Technologies Recalls Lidocaine Wound Gel
Water-Jel Technologies, LLC · Class III — Regulatory

Product Description
Lidocaine Wound Gel (Benzalkonium Chloride, 0.13% and Lidocaine Hydrochloride, 2%), NET WT 0.5 OZ (14 g), Distributed by: CVS PHarmacy, INc., One CVS Drive, Woonsocket, RI 02895. NDC 59898-950
Reason for Recall
Failed PH Specifications
FDA Classification
Class III — Regulatory
A situation in which use of, or exposure to, a violative product is not likely to cause adverse health consequences.
Distribution
Nationwide in the USA
Remedy
Consumers should stop using this product. Contact the recalling firm for further instructions regarding this product.
411 Press Analysis
The FDA has classified this as a Class III recall — the lowest severity level — for a pharmaceutical product recalled by Water-Jel Technologies, LLC on April 7, 2026. Failed PH Specifications. This recall covers 31,488 tubes, distributed nationwide. Class III recalls typically involve products unlikely to cause health problems but that violate FDA manufacturing or labeling regulations.
Sources: FDA openFDA Enforcement Database
This recall appears in: Drug & Medication Defects.